Demonstrates a rhodamine probe's efficacy for iron sensing and treating anemia in Drosophila, suggesting dual applications.
The development of functional organic molecules for advanced biological and environmental applications is of growing interest, particularly for metal ion sensing and therapeutic delivery. Rhodamine-based fluorescent compounds have been widely studied due to their well-defined absorption and emission properties. In this study, a rhodamine-appended fluorescent probe (RhB-A) was designed and synthesized, exhibiting strong fluorescence upon excitation at 400 nm. The probe demonstrates exceptional selectivity for Fe3+ ions, with significant fluorescence quenching even in the presence of 16 competing metal ions, with a LOD of 0.285 ppm in a semiaqueous medium, below the WHO guideline for iron in drinking water. Further, the Fe3+-coordinated complex was isolated as single crystals, confirming a 1:2 metal-to-ligand binding ratio. UV–Vis absorption studies further verified a reversible binding mechanism, supporting the probe’s potential as a reusable sensor. Computational studies supported the ligand’s reactivity and bioactivity, consistent with its experimental selectivity as a sensor. Importantly, the Fe3+ complex effectively treated lead-induced anemia in Drosophila melanogaster, delivering iron to deficient cells in a controlled and targeted manner. Thus, the designed fluorescent probe and its Fe3+ complex exhibited dual potential as a selective Fe3+ sensor and an anemia treatment agent.
No takes yet. Share an insight, caveat, or question.
Samal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: